Virtual Symposium
March 12–13, 2025

Background

Polycystic kidney diseases (PKD) comprise a group of renal cystic disorders that are accompanied by a broad array of extrarenal manifestations. These disorders are a major cause of morbidity in adults and children. Autosomal dominant PKD is the most common single gene disorder that results in end‑stage kidney disease. Autosomal recessive PKD is rare but more severe, resulting in perinatal mortality in 30–40% of affected infants. Although the most common causative genes for PKD (i.e., PKD1, PKD2, and PKHD1) were identified more than 2 decades ago, we still lack effective therapies, and major questions remain in our understanding of disease pathogenesis. The PKD RRC seeks to address these gaps by creating a collaborative framework that develops and shares research resources to support innovation in PKD research.

The PKD RRC is composed of a central coordinating site (University of Maryland, Baltimore); three research and translation core centers (The University of Alabama at Birmingham; The University of Kansas Medical Center; University of Maryland, Baltimore); and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Meeting Objectives

Organizing Committee

Patricia Outeda Garcia—Co-Chair, (University of Maryland School of Medicine); Pamela Tran—Co-Chair (The University of Kansas Medical Center); Terry Watnick, Nicole M. Reed, Feng Qian, and Owen Woodward (University of Maryland School of Medicine); Darren Wallace, Alan Yu, and Duuamene Nyimanu (The University of Kansas Medical Center); CJ Haycraft, Michal Mrug, John Parant, and Sreelakshmi Cherakara (The University of Alabama at Birmingham); Christine Maric-Bilkan (National Institutes of Health—NIDDK).

Registration Deadline

March 7, 2025